6.
Hua Q, Fan L, Li J
. 2019 Chinese guideline for the management of hypertension in the elderly. J Geriatr Cardiol. 2019; 16(2):67-99.
PMC: 6431598.
DOI: 10.11909/j.issn.1671-5411.2019.02.001.
View
7.
Marup F, Thomsen M, Birn H
. Additive effects of dapagliflozin and finerenone on albuminuria in non-diabetic CKD: an open-label randomized clinical trial. Clin Kidney J. 2024; 17(1):sfad249.
PMC: 10768792.
DOI: 10.1093/ckj/sfad249.
View
8.
Yu J, Park S, Lee D, Kim N, Seo J
. GLP-1 receptor agonists in diabetic kidney disease: current evidence and future directions. Kidney Res Clin Pract. 2022; 41(2):136-149.
PMC: 8995488.
DOI: 10.23876/j.krcp.22.001.
View
9.
Baek J, Lee E, Jung H, Jang I
. Geriatrics Fact Sheet in Korea 2021. Ann Geriatr Med Res. 2021; 25(2):65-71.
PMC: 8272996.
DOI: 10.4235/agmr.21.0063.
View
10.
Wang X, Yang C, Jiang J, Hu Y, Hao Y, Dong J
. Polypharmacy, chronic kidney disease, and mortality among older adults: A prospective study of National Health and nutrition examination survey, 1999-2018. Front Public Health. 2023; 11:1116583.
PMC: 10077868.
DOI: 10.3389/fpubh.2023.1116583.
View
11.
Sumida K, Yamagata K, Kovesdy C
. Constipation in CKD. Kidney Int Rep. 2020; 5(2):121-134.
PMC: 7000799.
DOI: 10.1016/j.ekir.2019.11.002.
View
12.
Kim H, Hyun Y, Yun H, Joo Y, Kim Y, Jung J
. Predictive performance of the new race-free Chronic Kidney Disease Epidemiology Collaboration equations for kidney outcome in Korean patients with chronic kidney disease. Kidney Res Clin Pract. 2023; 42(4):501-511.
PMC: 10407639.
DOI: 10.23876/j.krcp.22.158.
View
13.
Kim H, Jeong S, Kim K, Hwang S, Choi S, Lee H
. Trends in clinical outcomes of older hemodialysis patients: data from the 2023 Korean Renal Data System (KORDS). Kidney Res Clin Pract. 2024; 43(3):263-273.
PMC: 11181040.
DOI: 10.23876/j.krcp.23.267.
View
14.
Vart P, Butt J, Jongs N, Schechter M, Chertow G, Wheeler D
. Efficacy and Safety of Dapagliflozin in Patients With Chronic Kidney Disease Across the Spectrum of Frailty. J Gerontol A Biol Sci Med Sci. 2023; 79(2).
PMC: 10809037.
DOI: 10.1093/gerona/glad181.
View
15.
Melamed M, Raphael K
. Metabolic Acidosis in CKD: A Review of Recent Findings. Kidney Med. 2021; 3(2):267-277.
PMC: 8039421.
DOI: 10.1016/j.xkme.2020.12.006.
View
16.
Cirillo M, Laurenzi M, Mancini M, Zanchetti A, De Santo N
. Low muscular mass and overestimation of microalbuminuria by urinary albumin/creatinine ratio. Hypertension. 2005; 47(1):56-61.
DOI: 10.1161/01.HYP.0000197953.91461.95.
View
17.
Albertus P, Morgenstern H, Robinson B, Saran R
. Risk of ESRD in the United States. Am J Kidney Dis. 2016; 68(6):862-872.
PMC: 5123906.
DOI: 10.1053/j.ajkd.2016.05.030.
View
18.
Coresh J, Astor B, Greene T, Eknoyan G, Levey A
. Prevalence of chronic kidney disease and decreased kidney function in the adult US population: Third National Health and Nutrition Examination Survey. Am J Kidney Dis. 2002; 41(1):1-12.
DOI: 10.1053/ajkd.2003.50007.
View
19.
Stone N, Grundy S
. The 2018 AHA/ACC/Multi-Society Cholesterol guidelines: Looking at past, present and future. Prog Cardiovasc Dis. 2019; 62(5):375-383.
DOI: 10.1016/j.pcad.2019.11.005.
View
20.
. Clinical and cost-effectiveness of oral sodium bicarbonate therapy for older patients with chronic kidney disease and low-grade acidosis (BiCARB): a pragmatic randomised, double-blind, placebo-controlled trial. BMC Med. 2020; 18(1):91.
PMC: 7144058.
DOI: 10.1186/s12916-020-01542-9.
View